Assessing the potential clinical impact of reciprocal drug approval legislation on access to novel therapeutics in the USA: a cohort study

OBJECTIVE: To quantify the potential effect of reciprocal approval legislation on access to clinically impactful therapeutics in the USA. DESIGN: A cohort study. SETTING: New therapeutics approved by the Food and Drug Administration (FDA), European Medicines Agency (EMA) and/or Health Canada between...

Descripción completa

Detalles Bibliográficos
Autores principales: Larochelle, Matthieu, Downing, Nicholas S, Ross, Joseph S, David, Frank S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306516/
https://www.ncbi.nlm.nih.gov/pubmed/28179418
http://dx.doi.org/10.1136/bmjopen-2016-014582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306516/
https://www.ncbi.nlm.nih.gov/pubmed/28179418
http://dx.doi.org/10.1136/bmjopen-2016-014582

Ejemplares similares